文献速递心境障碍

静脉氯胺酮对注意偏倚的影响:在两项临床研究中探究快速抗抑郁作用的机制

The Impact of Intravenous Ketamine on Attentional Bias: Probing Mechanisms of Rapid-Acting Antidepressant Effects in Two Clinical Studies.
PubMed 文献 · Biol Psychiatry · 2024-11-22

两项临床研究采用新型双探测视频任务测量抑郁患者对悲伤影片的注意偏倚(AB),评估该任务的重测信度与效度,并观察单次静脉氯胺酮(0.5 mg/kg,输注40分钟)对AB的影响及其与抗抑郁疗效的关系。结果显示该任务在氯胺酮治疗前具有良好的一周和一月重测信度,两项研究中患者从输注前到输注后24小时均出现AB显著降低,且AB变化与症状改善相关。

要点

  • 新型双探测视频任务测量的注意偏倚指标在氯胺酮治疗前表现稳定,具有良好的一周和一月重测信度。
  • 两项研究中,抑郁患者从氯胺酮输注前到输注后24小时均出现注意偏倚显著降低。
  • 研究2中注意偏倚的变化与输注前后症状改善相关,研究1中治疗前各次评估时注意偏倚与临床医生评定的抑郁症状存在横断面相关。

核心结论

  • 结果支持一种新型、心理测量学稳健的注意偏倚测量工具在抑郁个体中的效度。
  • 研究发现氯胺酮可靠且快速地降低注意偏倚,为理解其抗抑郁作用中可重复的潜在认知机制提供了线索。

研究设计与样本

  • 研究1:寻求治疗的成人中重度抑郁患者(N=40)在基线、1周重测和1月重测时完成任务;其中一部分参与者(n=15)还在氯胺酮输注(0.5 mg/kg,40分钟)后24小时完成任务。
  • 研究2:参与者(N=43)在氯胺酮输注前和输注后24小时完成任务。
  • 采用新型双探测视频任务来索引对悲伤影片的注意偏倚。

主要发现

  • 新型注意偏倚任务的指标在氯胺酮治疗前表现稳定,显示出良好的一周和一月重测信度。
  • 两项研究的参与者从氯胺酮输注前到输注后24小时均表现出注意偏倚的显著降低。
  • 研究1中,在每次治疗前评估时均观察到注意偏倚与临床医生评定的抑郁症状之间存在横断面相关。
  • 研究2中,注意偏倚的变化与输注前后症状改善相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Ketamine is known for its rapid antidepressant effect, but its impact on affective information processing (including attentional bias [AB], a putative cognitive mechanism of depression) remains largely unexplored. We leveraged a novel measurement of AB and sought to 1) establish adequate test-retest reliability and validity among participants with depression prior to ketamine treatment and 2) harness a single dose of ketamine to assess mechanistic shifts in AB and their relationship to antidepressant efficacy. METHODS: A novel dual probe video task was used to index AB toward sad film clips. In study 1, treatment-seeking adults with moderate-to-severe depression (N = 40) completed the task at baseline, 1-week retest, and 1-month retest; a subset of participants (n = 15) also performed the task at 24 hours postketamine infusion (0.5 mg/kg over 40 minutes). In study 2, participants (N = 43) completed the task pre- and 24 hours postketamine. RESULTS: Indices from the novel AB task were stable prior to ketamine, demonstrating good 1-week and 1-month test-retest reliability. Participants in both studies exhibited a robust reduction in AB from pre- to 24 hours postketamine infusion. In study 1, cross-sectional correlations were observed between AB and clinician-rated depressive symptoms at each pretreatment assessment. In study 2, changes in AB were correlated with improved symptoms from pre- to postinfusion. CONCLUSIONS: Results provide evidence for the validity of a novel, psychometrically robust measure of AB among individuals with depression. Findings indicate that ketamine reliably and rapidly reduces AB, offering insight into a replicable, potential cognitive mechanism involved in its antidepressant action.

来源:Biol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Woody ML, Rohac R, Cooper I, et al. The Impact of Intravenous Ketamine on Attentional Bias: Probing Mechanisms of Rapid-Acting Antidepressant Effects in Two Clinical Studies. Biol Psychiatry. 2024. PMID: 39581291. doi:10.1016/j.biopsych.2024.10.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。